AdiraMedica

AdiraMedica LLC was co-founded by Martin Jeiven and Arvind Bhandari in September of 2006 to provide Global Clinical Trial Sourcing Services to pharmaceutical, biotechnology and medical device companies. Over the years, AdiraMedica has expanded its service offerings to include: Global Clinical Trial Supply Services, Global Supply Chain Management Services and Wholesale Distribution. CORE CAPABILITIES Global Clinical Trial Sourcing - Comparator Drugs - Reference Listed Drugs - Ancillary Supplies & Equipment Global Clinical Packaging - Secondary Packaging - Labeling - Storage and Distribution - Returns, Reconciliation and Destruction Global Supply Chain Management - Clinical/Commercial products - Import/Export - 3PL Warehousing & Distribution Wholesale Distribution - Branded and Generic Pharmaceuticals - Biologics - Controlled Drugs COMPLIANCE - Fully equipped CGMP facility - Refrigerated, frozen and controlled ambient storage with security systems - Wholesale, distributor and DEA licenses - Compliance to CGMP, GCP and ICH regulations and industry best- practices AdiraMedica is a Nationally Certified Minority Business Enterprise

akt health inc.

AKT Health was founded in 2017 in Japan & India by a team of Techno-functional experts in Clinical, Medical & Commercial fields. As a Clinical & Medical partner with life science companies and health systems, we develop market-leading strategies for long-term top performance, engagement, growth, and sustainability. Our teams evaluate data, apply analytical models, study systems, and analyze workflows to open up opportunities to improve performance through effective use of technology and engagement planning. We work with healthcare stakeholders to implement improved processes and create efficiencies that can withstand changes within the industry. Applied Knowledge & Technology in Healthcare – a philosophy on which AKT Health stands. This is reflected in our three Expert Solutions in Consulting, Technology, and Intelligence. Each is focussed to address the needs of Pharmaceutical, Medical Device and Biotechnology firms. Apart from traditional support to Clinical & Medical operations, Our recent projects include - AI driven KOL Mapping & Rising Star Identification - Patient Identification & Recruitment using AI - Decentralized Clinical trials using RPM (Remote Patient Monitoring) - Evidence generation & AI Integration in Clinical trials - Blockchain based Supply Chain Management system - AI Drive Omnichannel approach in Medical Affairs - Salesforce Optimization for Commercial teams Our key - Office in 9 Countries with partners for Site Management & Field work in 18 Countries - 90+ Employees mainly based in India, Japan, Taiwan & USA (Boston) - 50+ projects delivered globally - Key Therapeutic areas - Oncology, Cardiovascular, CNS, Gastroenterology & Others We are the sole distributors and promoters of Certara's industry-standard software. For more information, write to us at info@akthealth.com or call +91 7997776410/ 040-48598251

Drugzone Pharmaceuticals Inc

Generic Drug wholesaler

Apertus Pharmaceuticals

API MANUFACTURING: Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our focus is providing bulk (Schedule II–V) controlled actives, however non-controlled APIs are also within our project portfolio. ANALYTICAL SERVICES: Apertus performs analytical methods development and services on a variety of instrument platforms. Our primary focus is LC (UV), LCMS and GCMS. We can use existing methods or develop novel methods on a per-project basis. In addition, we can provide methods validation, impurity identification and tech transfer packages. PHARMACEUTICAL SERVICES: Apertus provides services for drug discovery and preclinical development on a kilo-lab scale. We can supply intermediates, specialty chemical synthesis, process optimization and scale-up services. In addition we can aid in characterizing RLDs via dissolution profiles, chemical analysis and microscopy. All services can be provided under cGMP.

Radionetics Oncology

Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.